Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities
Authors
Keywords
-
Journal
Nature Communications
Volume 13, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-01-26
DOI
10.1038/s41467-022-27987-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative analysis of the AIB1 interactome in breast cancer reveals MTA2 as a repressive partner which silences E-Cadherin to promote EMT and associates with a pro-metastatic phenotype
- (2021) Damir Varešlija et al. ONCOGENE
- Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment
- (2021) Carlota Rubio-Perez et al. Nature Communications
- Radiotherapy is associated with a deletion signature that contributes to poor outcomes in patients with cancer
- (2021) Emre Kocakavuk et al. NATURE GENETICS
- Subtype switching in breast cancer brain metastases: a multicenter analysis
- (2020) Alexander F C Hulsbergen et al. NEURO-ONCOLOGY
- Neurofibromin Is an Estrogen Receptor-α Transcriptional Co-repressor in Breast Cancer
- (2020) Ze-Yi Zheng et al. CANCER CELL
- Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
- (2020) Florian Klemm et al. CELL
- The genomic landscape of metastatic breast cancer: Insights from 11,000 tumors
- (2020) Jacob Rinaldi et al. PLoS One
- CoMut: visualizing integrated molecular information with comutation plots
- (2020) Jett Crowdis et al. BIOINFORMATICS
- Brain Metastasis Cell Lines Panel: a public resource of organotropic cell lines
- (2020) Manuel Valiente et al. CANCER RESEARCH
- Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity
- (2020) Jørgen Smeby et al. EBioMedicine
- TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- PARP inhibitor resistance and TP53 mutations in patients treated with olaparib for BRCA-mutated cancer: Four case reports
- (2020) Thomas Collot et al. Molecular Medicine Reports
- Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
- (2019) Oscar M. Rueda et al. NATURE
- Hematopoietic stem cell gene therapy for brain metastases using myeloid cell-specific gene promoters
- (2019) Tereza Andreou et al. JNCI-Journal of the National Cancer Institute
- Impact of breast cancer molecular subtypes on the incidence, kinetics and prognosis of central nervous system metastases in a large multicentre real-life cohort
- (2019) Amélie Darlix et al. BRITISH JOURNAL OF CANCER
- Patterns of recurrence and metastasis in BRCA1/BRCA2 ‐associated breast cancers
- (2019) Yun Song et al. CANCER
- Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors
- (2019) Li Zhu et al. Journal for ImmunoTherapy of Cancer
- BRCA1 Mutations Associated With Increased Risk of Brain Metastases in Breast Cancer
- (2018) Peter J. Zavitsanos et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors
- (2018) M Diossy et al. ANNALS OF ONCOLOGY
- A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity
- (2018) Norman Sachs et al. CELL
- Epigenome-wide SRC-1–Mediated Gene Silencing Represses Cellular Differentiation in Advanced Breast Cancer
- (2018) Elspeth Ward et al. CLINICAL CANCER RESEARCH
- Integrated RNA and DNA sequencing reveals early drivers of metastatic breast cancer
- (2018) Marni B. Siegel et al. JOURNAL OF CLINICAL INVESTIGATION
- Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets
- (2018) Damir Varešlija et al. JNCI-Journal of the National Cancer Institute
- STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis
- (2018) Neibla Priego et al. NATURE MEDICINE
- Reactive astrocytic S1P3 signaling modulates the blood–tumor barrier in brain metastases
- (2018) Brunilde Gril et al. Nature Communications
- Transcriptome Characterization of Matched Primary Breast and Brain Metastatic Tumors to Detect Novel Actionable Targets
- (2018) Damir Varešlija et al. JNCI-Journal of the National Cancer Institute
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term treatment with the PARP inhibitor niraparib does not increase the mutation load in cell line models and tumour xenografts
- (2018) Ádám Póti et al. BRITISH JOURNAL OF CANCER
- Widespread Selection for Oncogenic Mutant Allele Imbalance in Cancer
- (2018) Craig M. Bielski et al. CANCER CELL
- A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
- (2018) Marta Castroviejo‐Bermejo et al. EMBO Molecular Medicine
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- A mutational signature reveals alterations underlying deficient homologous recombination repair in breast cancer
- (2017) Paz Polak et al. NATURE GENETICS
- DGIdb 3.0: a redesign and expansion of the drug–gene interaction database
- (2017) Kelsy C Cotto et al. NUCLEIC ACIDS RESEARCH
- Molecular characterization of breast cancer CTCs associated with brain metastasis
- (2017) Debasish Boral et al. Nature Communications
- Intrinsic Subtype Switching and Acquired ERBB2/HER2 Amplifications and Mutations in Breast Cancer Brain Metastases
- (2017) Nolan Priedigkeit et al. JAMA Oncology
- Complex heatmaps reveal patterns and correlations in multidimensional genomic data
- (2016) Zuguang Gu et al. BIOINFORMATICS
- Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
- (2016) M. L. Telli et al. CLINICAL CANCER RESEARCH
- Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer
- (2015) Deena M. A. Gendoo et al. BIOINFORMATICS
- 14-3-3ζ Turns TGF-β’s Function from Tumor Suppressor to Metastasis Promoter in Breast Cancer by Contextual Changes of Smad Partners from p53 to Gli2
- (2015) Jia Xu et al. CANCER CELL
- Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
- (2015) Jodi M Saunus et al. JOURNAL OF PATHOLOGY
- Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth
- (2015) Lin Zhang et al. NATURE
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
- (2015) P. K. Brastianos et al. Cancer Discovery
- Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis
- (2014) Manuel Valiente et al. CELL
- Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs
- (2012) Christopher T. Saunders et al. BIOINFORMATICS
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Genes that mediate breast cancer metastasis to the brain
- (2009) Paula D. Bos et al. NATURE
- Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt
- (2009) Steffen Durinck et al. Nature Protocols
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More